i
Population-based Laboratory Surveillance for AmpC β-Lactamase–producing Escherichia coli, Calgary
-
Published Date:
Mar 2007
Source:Emerg Infect Dis. 13(3):443-448.
[PDF-215.34 KB]
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:In the Calgary Health Region during 2000-2003, prospective, active, population-based laboratory surveillance for all cefoxitin-resistant Escherichia coli isolates was performed. Isolates were screened with an inhibitor-based disk test, and plasmid-mediated types were identified by multiplex PCR with sequencing. A total of 369 AmpC beta-lactamase-producing E. coli isolates were identified; annual incidence rates were 1.7, 4.3, 11.2, and 15 per 100,000 residents for each year, respectively. AmpC beta-lactamase-producing E. coli was 5x more likely to be isolated from female than male patients across all age groups except < 1 year. Of these isolates, 83% were community onset, and urine was the principal site of isolation (90% of patients). PCR showed that 125 (34%) were positive for bla(cmy) genes; sequencing identified these enzymes to be CMY-2. In this large Canadian region, AmpC beta-lactamase-producing E. coli is an emerging community pathogen that commonly causes urinary tract infections in older women.
-
Subject:
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
File Type:
-
Supporting Files:
text/plain 
image/gif 
image/jpeg 
image/gif 
image/jpeg 
image/gif 
image/jpeg
text/plain
No Related Documents.
You May Also Like:
-
[PDF - 453.43 KB]
Published Date:Source:Description:File Type:[PDF - 453.43 KB]
File Type:[PDF - 453.43 KB]
[PDF - 113.14 KB]
Published Date:Source:Description:File Type:[PDF - 113.14 KB]
File Type:[PDF - 113.14 KB]
[PDF - 311.39 KB]
Published Date:Source:File Type:[PDF - 311.39 KB]
File Type:[PDF - 311.39 KB]
[PDF - 155.39 KB]
Published Date:Source:Description:File Type:[PDF - 155.39 KB]
File Type:[PDF - 155.39 KB]
[PDF - 273.71 KB]
Published Date:Source:Description:File Type:[PDF - 273.71 KB]
File Type:[PDF - 273.71 KB]
Have Questions?
Visit CDC Info
Email
CDC-INFO
Open 24/7
CDC INFORMATION
CONNECT WITH CDC
